Drug Combo Shows Promise Against Advanced Head and Neck Cancer

MONDAY, April 3, 2023 -- An experimental targeted drug could provide a fresh chance for people with recurring head and neck cancer that has grown resistant to other treatments, a new clinical trial says. Ficlatuzumab used in combination with the...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news